Clinical Trials Logo

Clinical Trial Summary

Rationale: Intestinal permeability of subjects can vary depending on their health status. It is therefore important to be able to measure and quantify intestinal permeability in a standardized way. Subjects with intestinal complaints (like irritable bowel disorder) or obese subjects have been found to have increased intestinal permeability. Different physiological conditions might affect intestinal permeability (IP) further.

In the clinic, sugar absorption tests and different blood and urine markers have been used to quantify IP. The sugars sucrose, mannitol, sucralose and lactulose are absorbed differently in the small or large intestines, resulting in different sugar levels in urine. This indicates the level of intestinal permeability and the location of increased permeability which is more or less permeable.

A high-fat meal could be used as a challenge test to increase IP in subjects even further. After a high fat meal, lipopolysaccharide (LPS) could be co-transported with chylomicrons. Small amounts of LPS co-transit with dietary fat from the gut after a high-fat meal, which thereby increases plasma LPS concentrations.

Because of the above mentioned reasons, it could be relevant to determine intestinal permeability and plasma LPS concentration after consumption of a high-fat diet.

Different methods will be used to determine the intestinal permeability in lean and obese men, under different conditions. New parameters, like intestinal (I) fatty acid binding protein (I-FABP), liver (L)-FABP, LPS and inflammatory markers will be measured and related to outcomes of tests, to examine the relation with intestinal permeability.

The association of IP with whole body electrical resistance will be examined, to determine usefulness of a candidate non-invasive method for IP investigation.


Clinical Trial Description

Study design: The study is designed as a randomized, cross-over and open study.

Study population: 16 healthy, lean (BMI 20-25 kg.m-2) and obese (BMI 30-35 kg.m-2) male subjects will participate in the study, aged between 18-45 years.

Intervention: On two different test days eight lean and eight obese men will be supplied with a sugar drink to examine intestinal permeability under normal conditions and in combination with an oral fat load to examine intestinal permeability under stressed conditions.

Main study parameters/endpoints: Intestinal permeability will be examined with an absorption test using four different sugars (sucrose, mannitol, sucralose and lactulose). New markers of intestinal permeability, like I-FABP, L-FABP, LPS and inflammatory markers will be measured as well. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms


NCT number NCT01049386
Study type Interventional
Source TNO
Contact
Status Completed
Phase Phase 2
Start date January 2010
Completion date February 2010

See also
  Status Clinical Trial Phase
Completed NCT03957239 - The Effect of a Cranberry Beverage on Intestinal Permeability and Gastrointestinal Function in Generally Healthy Adults N/A
Recruiting NCT04543877 - WHNRC (Western Human Nutrition Research Center) Fiber Intervention Study Early Phase 1
Recruiting NCT04109352 - Labelled Carbon Sucrose Breath Test (13C-SBT) as a Marker of Environmental Enteropathy
Completed NCT01424306 - Diet and Systemic Inflammation N/A
Completed NCT01241201 - Intestinal Barrier Function and Probiotics. N/A
Completed NCT01477034 - Vitamin D and Adipose Tissue Inflammation N/A
Recruiting NCT05257200 - Gut Permeability and Bariatric-metabolic Surgery
Completed NCT03027583 - The Effect of Probiotic Intervention on Intestinal Permeability N/A
Completed NCT03704727 - The Effects of Probiotics on Intestinal Permeability in Gastrointestinal Cancer Patients in Chemotherapy N/A
Recruiting NCT04979130 - Comparing Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB) Phase 4
Recruiting NCT06262880 - Dietary Supplementation on Gastrointestinal Barrier Function N/A
Completed NCT01756040 - Intestinal Permeability in Preterm Infants Phase 1
Active, not recruiting NCT04083950 - Induction of Gut Permeability by an Oral Vaccine Early Phase 1
Completed NCT03113240 - Trial of Enteral Glutamine on Intestinal Permeability in Critically Ill Patients Phase 3